The effect of SGLT2 inhibitor on clinical outcomes in patients with type 2 diabetes and atrial fibrillation

被引：0
|
作者：
Shin, S. H. [1 ]
Cho, Y. [1 ]
Park, M. A. [2 ]
Jang, J. H. [1 ]
Kim, D. Y. [1 ]
Kim, S. H. [1 ]
机构：
[1] Inha Univ Hosp, Incheon, South Korea
[2] Hanmi, Seoul, South Korea
来源：
EUROPEAN HEART JOURNAL | 2023年 / 44卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Is an SGLT2 inhibitor right for your patient with type 2 diabetes?
    Lisenby, Katelin M.
    Meyer, Allison
    Slater, Nicole A.
    JOURNAL OF FAMILY PRACTICE, 2016, 65 (09): : 587 - 593
  • [22] Insulin Independence With SGLT2 Inhibitor Use in Type 2 Diabetes
    Jack, Gwendolyne Anyanate
    Kashyap, Sangeeta R.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2023, 108 (10): : E1153 - E1154
  • [23] Ketoacidosis in Type 2 Diabetes with and without SGLT2 Inhibitor Therapy
    Koerbel, Theresa
    Zitterl, A.
    Jagoutz, T.
    Peric, S.
    Stulnig, T. M.
    WIENER KLINISCHE WOCHENSCHRIFT, 2023, 135 : S765 - S765
  • [24] Clinical implication of SGLT2 inhibitors in type 2 diabetes
    Kim, Go Woon
    Chung, Sung Hyun
    ARCHIVES OF PHARMACAL RESEARCH, 2014, 37 (08) : 957 - 966
  • [25] Clinical implication of SGLT2 inhibitors in type 2 diabetes
    Go Woon Kim
    Sung Hyun Chung
    Archives of Pharmacal Research, 2014, 37 : 957 - 966
  • [26] Canagliflozin: A Novel SGLT2 Inhibitor for Type 2 Diabetes Mellitus
    Kaushal, Shaveta
    Singh, Harmanjit
    Thangaraju, Pugazhenthan
    Singh, Jasbir
    NORTH AMERICAN JOURNAL OF MEDICAL SCIENCES, 2014, 6 (03) : 107 - 113
  • [27] Canagliflozin, a Novel SGLT2 Inhibitor for Treatment of Type 2 Diabetes
    Nigro, Stefanie C.
    Riche, Daniel M.
    Pheng, Michelle
    Baker, William L.
    ANNALS OF PHARMACOTHERAPY, 2013, 47 (10) : 1301 - 1311
  • [28] RENOPROTECTIVE EFFECT OF SGLT2 INHIBITOR DAPAGLIFLOZIN IN TYPE-1 DIABETES
    Balogh, Dora
    Hodrea, Judit
    Lenart, Lilla
    Hosszu, Adam
    Szkibinszkij, Edgar
    Vannay, Adam
    Wagner, Laszlo
    Szabo, Attila
    Fekete, Andrea
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2017, 32
  • [29] Dapagliflozin, an SGLT2 inhibitor, for diabetes
    Hanefeld, Markolf
    Forst, Thomas
    LANCET, 2010, 375 (9733): : 2196 - 2198
  • [30] Effect of the SGLT2 Inhibitor Dapagliflozin on Potassium Levels in Patients with Type 2 Diabetes Mellitus: A Pooled Analysis
    Yshai Yavin
    Traci A. Mansfield
    Agata Ptaszynska
    Kristina Johnsson
    Shamik Parikh
    Eva Johnsson
    Diabetes Therapy, 2016, 7 : 125 - 137
12345